€200Mln Pharma and CDMO investment (2015) by Sanofi for Insulin at Industriepark Höchst in Germany
About this project
Pharma and CDMO investment of € 200 mln by Sanofi at Industriepark Höchst in Germany, Europe, targeting the production of Insulin.
Investment details
| Park | Industriepark Höchst (DE) |
|---|---|
| Amount | € 200 mln |
| Categories | Pharma, CDMO |
| Investors | 
Sanofi |
| Target substances |
Insulin
Product
|